NPPB and heart failure: A small double-blind, placebo-controlled trial of subjects with heart failure with reduced ejection fraction treated with benzbromarone did not demonstrate any improvement in brain natriuretic peptide, left ventricular ejection fraction, echocardiographic assessment of cardiac dimensions, despite a significant decrease in SUA (Ogino et al., 2010).